This website uses cookies to ensure you get the best experience on our website. Privacy Policy
UroToday UroToday
  • Contact
  • Login
  • Sign Up Free
  • Transformative Evidence
    • mCRPC
      • Genomic Biomarker Testing
      • PEACE-3 Trial
      • PROfound Trial
      • PSMAfore Trial
      • The RALU Study: Treatment Considerations in the First Line Setting of mCRPC
      • VISION Trial
    • mHSPC
      • ARANOTE Trial
      • ARASENS Trial
    • nmCRPC
      • ARAMIS Trial
    • nmCSPC
      • EMBARK Trial
    • PSMA PET Imaging
      • COBRA Trial
      • CONDOR Trial
      • OSPREY Trial
    • Bladder Cancer
      • Bladder Cancer Detection
      • BOND-003 Cohort P
      • CORE-001 Study
      • CORE-008
  • Centers of Excellence
    • Urologic Oncology
      • Left Group
        • Health Policy
          • Health Policy
            Daniel D. Joyce, MD, MS
        • Bladder Cancer
          • Non-Muscle Invasive Bladder Cancer
            Ashish Kamat, MD
          • Muscle-Invasive Bladder Cancer
          • Advanced & Metastatic Bladder Cancer (mUC)
          • Trimodality Therapy
            Leslie Ballas, MD
        • Kidney Cancer
          • Advanced Kidney Cancer
            Pedro Barata, MD, MSc
        • Endourology
          • Endourology
            Jaime Landman, MD
      • Prostate Cancer
        • Localized Prostate Cancer
          Matthew R. Cooperberg, MD, MPH
        • Decipher® Genomic Classifier
        • Imaging Center
          Phillip Koo, MD
        • mHSPC
          Neeraj Agarwal, FASCO, MD
        • nmCRPC
          Zachary Klaassen, MD, MSc
        • mCRPC Treatment
          A. Oliver Sartor, MD
        • mCRPC with Bone Metastasis
        • PSMA-Targeted Therapy
        • Advanced Prostate Cancer
          Zachary Klaassen, MD, MSc
      • Disparities: Social Determinants of Health
        • Disparities: Social Determinants of Health
          Samuel L. Washington III, MD, MAS
      • Translational Prostate Cancer
        • Translational Science in Prostate Cancer
          Andrea Miyahira, Ph.D
        • Women in Science
          Andrea Miyahira, Ph.D
      • Upper Tract Urothelial Carcinoma
        • Upper Tract Urothelial Carcinoma
          Sam S. Chang, MD, MBA
      • Testicular, Penile & Rare GU Malignances
        • Testicular Cancer
    • Functional Urology
      • Functional Urology
        Alan J. Wein, MD, PhD (hon.)
      • Urologic Catheters - CAUTI Challenges
  • Videos
    • Exclusives
      • Conferences
      • Disparities: Social Determinants of Health
      • Exclusive Collaborations
      • Health Policy in Urological Diseases
      • Independent Medical Education
      • Journal Clubs
      • Practice Guidelines Reviews
      • The Prostate Cancer Foundation
    • Urologic Oncology
      • Prostate Cancer
      • Bladder Cancer
      • Kidney Cancer
      • Upper Tract Urothelial Tumors
      • Testicular Cancer
      • Endourology
    • Functional Urology
      • Men's Health
      • Pelvic Health
  • Actionable Clinical Data
    • Bladder Cancer
      • NMIBC with CIS: Evidence, Practice & Emerging Research
      • Risk-Stratified NMIBC Management
  • Trials in Progress
    • Prostate Cancer
      • Localized Prostate Cancer
        • CLARIFY
        • ESCAPE
        • FORT
        • NRG-GU 0101
        • RTIRE
      • High Risk BCR HSPC
        • ARASTEP
      • Oligometastatic Prostate Cancer
        • METANOVA
      • mHSPC
        • ARASEC
        • ASPIRE
        • MEVPRO-3
      • mCRPC
        • ECLIPSE
        • LEGION-100
        • MEVPRO-1 & 2
        • PROMISE
        • SECuRE
    • Bladder Cancer
      • PIVOT-006
    • Kidney Cancer
      • RadiCal
      • SAMURAI
  • Clinical Trials
    • From the Editor
      • Search Clinical Trials
  • Articles
    • Urology (benign and malignant)
      • Urologic Oncology
      • Men's Health
      • Endourology & Stones
      • Pediatric Urology
      • COVID-19 and Genitourinary Cancers
    • Pelvic Health
      • Pelvic Health & Reconstruction
  • Conference Coverage
    • Recent Conferences
      • SNMMI 2026
      • ASCO 2026
      • AUA 2026
      • APCCC 2026
      • PSMA and Beyond 2026
    • All Conferences
      • View All
  • PCF
  1. UroToday Home
  2. Conference Highlights
  3. Society of Urologic Oncology (SUO) 22nd Annual Meeting

Society of Urologic Oncology (SUO) 22nd Annual Meeting

  • SUO 2021 Prostate Cancer
  • SUO 2021 Bladder Cancer
  • SUO 2021 Kidney Cancer
  • SUO 2021 Testicular and Penile Cancer
  • SUO 2021 Upper Tract Urothelial Carcinoma

SUO 2021 Bladder Cancer

Viewing 1-6 of 6 articles
SUO 2021: Clinical Informatic Strategies to Accelerate Research in Urologic Oncology
SUO 2021: Digital Innovations to Improve Perioperative Bladder Cancer Care
SUO 2021: Molecular Subtyping to Stratify the Treatment of Muscle-Invasive Bladder Cancer: A Cost-Effectiveness Analysis
SUO 2021: Safety, Tolerability, and Preliminary Efficacy of a Neoadjuvant Gemcitabine Intravesical Drug Delivery System (TAR-200) in Muscle-Invasive Bladder Cancer Patients: A Phase 1 Trial
SUO 2021: State of the Art: Cell Free DNA in Urine – Technical Challenges, Early Results and Potential Applications
SUO 2021: Economic Outcomes of Hexaminolevulinate Blue-Light Cystoscopy Compared with White Light Cystoscopy for Diagnosis and Monitoring of Non-Muscle Invasive Bladder Cancer: A 5-Year, Medicare-based Model
  • About UroToday
  • Journals
  • Calendar
  • Editorial and Advertising Guidelines
  • Editors and Contributors
  • FAQs
  • Privacy Policy
  • Terms of Use
Follow UroToday

COPYRIGHT © 2002 - 2026 DIGITAL SCIENCE PRESS, LLC

Login

Login to update email address, newsletter preferences and use bookmarks.

  • Forgot Password?
  • Sign Up Free